Inducible nitric oxide (NO) produced by macrophages is cytotoxic to invading organisms and has an important role in host defense. Recent studies have demonstrated inducible NO production within the heart, and that cytokine-induced NO mediates alterations in cardiac contractility, but the cytotoxic potential of nitric oxide with respect to the heart has not been defined. To evaluate the role of inducible nitric oxide synthase (iNOS) on cardiac myocyte cytotoxicity, we exposed adult rat cardiac myocytes to either cytokines alone or to activated J774 macrophages in coculture. Increased expression of both iNOS message and protein was seen in J774 macrophages treated with IFNy and LPS and cardiac myocytes treated with TNF-a, EL-1lf, and IFNy. Increased NO synthesis was confirmed in both the coculture and isolated myocyte preparations by increased nitrite production. Increased NO synthesis was associated with a parallel increase in myocyte death as measured by CPK release into the culture medium as well as by loss of membrane integrity, visualized by trypan blue staining. Addition of the competitive NO synthase inhibitor L-NMMA to the culture medium prevented both the increased nitrite production and the cytotoxicity observed after cytokine treatment in both the isolated myocyte and the coculture experiments. Because transforming growth-factor beta modulates iNOS expression in other cell types, we evaluated its effects on cardiac myocyte iNOS expression and NO-mediated myocyte cytotoxicity.
2). Proinflammatory cytokines are released locally in a variety of conditions associated with myocardial inflammation, including cardiac allograft rejection, myocardial infarction, myocarditis, and idiopathic cardiomyopathies (1) (2) (3) . In addition, elevated levels of circulating cytokines have been described in advanced heart failure (4, 5) . Because cytokines are potent inducers of nitric oxide synthesis in macrophages (6) (7) (8) (9) (10) (11) , smooth muscle cells (12) (13) (14) (15) , endothelial cells (9-11, 16, 17) , and cardiac myocytes (18), we investigated whether local production of nitric oxide by infiltrating macrophages and by cytokine-stimulated cardiac myocytes may be involved in the myocardial necrosis which often accompanies myocardial inflammation.
Nitric oxide is synthesized from the amino acid L-arginine by a family of enzymes, nitric oxide synthases (NOS) ' (14) . The constitutive isoform of NOS found in endothelial cells produces tiny puffs of NO, which serves as an important regulator of vasomotor tone, platelet aggregation, and neutrophil adhesivity to the vascular wall (9) (10) (11) . The constitutive isoform of NOS found in brain and in non-adrenergic noncholinergic neurons produces small amounts of NO which acts as a neurotransmitter (11) . In contrast, the cytokine-inducible isoform of NOS (iNOS) produces large quantities of NO over prolonged periods, and plays an important role in cells of monocyte/macrophage lineage, to defend the host against invading microorganisms (6) (7) (8) 19) . iNOS expression may not be entirely benign for the host organism or adjacent cells, however. Cytotoxic effects of large amounts of NO produced by iNOS in adjacent cells have been reported in tumor cells (20) (21) (22) , pancreatic islet cells (23) (24) (25) , neural cells (26, 27) , ovarian epithelial cells (28) , and hepatocytes (29) . In the cardiovascular system, NO produced by iNOS is a major pathophysiologic mediator of septic shock (9) (10) (11) , and has been shown to mediate in large part the negative inotropic effects of cytokines (30-33) . Although these effects of NO to inhibit myocyte contractility are well substantiated, and may mediate the negative inotropy observed in states such as sepsis (34) and cardiac transplant rejection (35) , the role of NO in myocyte killing remains speculative. Understanding the potentially lethal effects of NO on cardiac myocytes is important because not only are tissue-based macrophages and monocytes abundant within the heart, especially after infarction (36) and during periods of inflammation (1, 2, 37) and allograft rejection (35, (38) (39) (40) , but a cytokine-inducible NO synthase within cardiac myocytes themselves could serve as an endogenous high-output pathway for NO synthesis (18, [41] [42] [43] .
Accordingly, the present study was designed to test two hypotheses, that (a) NO produced by iNOS in activated macrophages can be lethal to adjacent adult cardiac myocytes, and (b) proinflammatory cytokines can induce iNOS expression in adult cardiac myocytes, and that NO so produced can be autotoxic to the cardiac myocytes. This study confirms these hypotheses, and may have important implications with respect to the pathophysiology of a broad range of inflammatory cardiac diseases, as well as to the pathogenesis of dilated cardiomyopathy.
Methods
Isolation of adult rat ventricular myocytes. Isolation and preparation of adult rat ventricular myocytes was based on a modification of previously described techniques (44, 45) . Male Wistar-Furth rats (250-300 g) were anesthetized and heparinized (1500 U/kg), after which their hearts were rapidly excised and placed in cold nominally calcium-free buffer. In aseptic fashion, perfusate was introduced into the cross-clamped aortic root at a constant rate (3-4 ml/min) using a Langendorff-type apparatus. An oxygenated, calcium-free perfusate was infused for the initial 5 min (NaCl 111 mM, KCl 5.4 mM, NaH2PO4 1.5 mM, MgCl2 1.6 mM, NaHCO3 4.2 mM, Hepes 20 mM, glucose 5.4 mM, L-glutamine 4.1 mM, and taurine 10 mM) (Sigma Chemical Co., St. Louis, MO), dissolved in MEM with MEM amino acid and vitamin supplement (GIBCO BRL, Grand Island, NY). After this initial perfusion was completed, collagenase B (final concentration 0.055%; Boehringer-Mannheim, Indianapolis, IN) was added and recirculating perfusion continued at 35°C for 25 min. The ventricles were minced and then placed into 10 ml of a digestion solution consisting of the base perfusion solution described above, to which 11 mg collagenase B, CaCl2 (final concentration 0.6 mM) and bovine serum albumin (5 gm/l) were added. The tissue was placed in a 33°C shaker, and every 15 min, the myocyte-rich solution was decanted and new digestion solution was added. This process was repeated 5-6 times. The decanted fractions were filtered through an autoclaved nylon mesh, pooled, and then subjected to percoll-density gradient centrifugation (46) (Sigma Chemical Co.). Myocytes sedimenting at the 1.082/ 1.062 g/ml interface were collected, washed 3 times, and resuspended in DME with 10% fetal bovine serum (Gemini Bioproducts, Calabasas, CA), 1% penicillin/streptomycin and 1% L-glutamine, and were plated on plasticware precoated with laminin (60 ,g per 100-mm dish for the Northern and Western blots, and 3.52 zg per well for 24-well plates; Sigma Chemical Co.). The medium was changed after 2 h to remove cellular debris and contaminating cells.
Preparation of J774.AJ macrophages. Mouse J774.Al cells of the monocyte/macrophage line (American Type Culture Collection, Rockville, MD) were cultured in a stirrer flask in DME with 10% fetal bovine serum, 2 mM L-glutamine, 50 Mg/ml penicillin, and 50 ,ug/ml streptomycin, and maintained at a cell density of 4-8 x 105 cells/ml by subculturing every 2-3 d (47) . For the coculture experiments, cells were plated on transwell plates (9 mm diameter, 45 .m pore size; Fisher Scientific, Pittsburgh, PA) at a density of 4.0 x 105 cells/well. For preparation of the Northern and Western blots, they were plated at a similar density on 100-mm tissue culture dishes. After 24 h, they were stimulated with IFNy (100 U/ml) and lipopolysaccharide (5 pg/ml) for an additional 24 h, or left unstimulated as indicated.
Myocyte/macrophage coculture experiments. Medium was changed in the 24-well myocyte plates 24 h after harvest, after which transwell inserts containing the J774 cells macrophages (prepared as described above) were placed over the myocyte lawn. After a 24-h period of coculture, the transwell inserts were removed and indices of myocyte death measured as described below. Measurement of myocyte death. Viability of ventricular myocytes was measured in two ways. Creatine phosphokinase (CPK) extruded into the supernatant was measured using a commercially available colorimetric assay (Sigma Chemical Co.). Its specificity for myocytes in the experimental system was confirmed by the virtually unmeasurable CPK levels in the supernatant of cytokine stimulated J774 cells maintained in the absence of myocytes, even after killing of the J774 cells with alcohol or freezing and thawing. After a 100-Ml aliquot of supernatant was removed for CPK assay, sodium hydroxide (0.1 N) was added to each well, and protein content was determined by the method of Lowry et al. (48) . CPK values (units/liter) were divided by the protein content (mg/ml) of each well to normalize for spurious variations in cell plating density. The ability of cardiac myocytes to exclude trypan blue was used as an index of membrane integrity, and was quantified by counting one hundred cells per well in a 24-well plate, with percent viability being defined as the percentage of cells that excluded trypan blue. Nitrite was measured in 100-,ul aliquots of supernatant from wells just prior to trypan blue staining, using the Griess reagent and measuring absorbance at 550 nm as described (49) . Sodium nitrite (Sigma Chemical Co.) served as the standard for these experiments.
Cytokine, LNMMA, and TGF-,f exposure. 24 h after primary culture of the myocytes (at the time of medium change), supplemental L-arginine (2 mM) was added in all experiments. At this same time, L-NMMA (10 mM; Calbiochem Corp., La Jolla, CA), and/or cytokines were added as indicated in the text. The added cytokines included recombinant human TNF-a (25 ng/ml; Genzyme, Cambridge, MA), IL-l-,6 (5 ng/ ml; Genzyme), and IFN-y (100 U/ml; Genzyme), and/or transforming growth factor B1 (recombinant human, 5 ng/ml; Genzyme). In all instances, the pH of the medium was adjusted to 7.4.
Northern analysis for iNOS. Poly(A) RNA was isolated from J774 macrophages or ventricular myocytes by oligo (dT) cellulose adsorption (Fast TrackTM RNA isolation kit k1593-02; Invitrogen, SanDiego, CA) (50). Equal amounts of poly(A) mRNA (1.2 jig) were electrophoresed in a 1% agarose formaldehyde gel, and then blotted by capillary transfer to nitrocellulose membranes. The blots were prehybridized for 6-8 h at 42°C in formamide (50%), SDS (0.1%), standard saline citrate (2X), Denhardt's solution (2x), denatured salmon testes DNA (0.125 mg/ml), and EDTA (1 mM) (pH 7.4). Hybridization was carried out at 42°C for 12-18 h with a murine iNOS probe generously provided by Dr. C. Nathan (Cornell University Medical College, New York, NY), and labeled with [32P]-dCTP to a specific activity of 1 x 106 cpm/,Lg of cDNA using a random primer labeling kit (Amersham Corp., Arlington Heights, IL), followed by washing under increasingly stringent conditions. Blots were then exposed to XAR-5 film (Eastman Kodak Co., Rochester, NY) with DuPont (Wilmington, DE) Cronex Lightening Plus intensifying screens at -70°C for 3-7 d. Human GAPDH cDNA labeled with [32p]_ dCTP was used in a second hybridization to confirm equal loading of each lane. Blots of freshly prepared samples were performed four times to confirm initial results.
Western analysis for iNOS. J774 cells or cardiac myocytes were lysed in a lysis buffer containing 150 mM NaCl, 1.0% NP-40, 0.1% SDS, 1 mM EDTA, and 50 mM Tris (pH 7.7), supplemented with protease inhibitors (10 jig/ml of antipain and leupeptin, and 1 mM PMSF), and centrifuged at 10,000 rpm for 20 min at 4°C. The cytosolic proteins (15 Al7.
experiments were designed to ascertain whether the inducible nitric oxide synthase expressed by activated J774.A1 macrophages was able to kill adjacent myocytes. As IFN-y and LPS are potent inducers of iNOS in macrophages (6, 51) . we first demonstrated that iNOS was induced in J774 macrophages under the conditions employed for coculture experiments with cardiac myocytes. Stimulation of J774 macrophages with IFN--y and LPS induced both iNOS message ( Fig. 1 A) and protein ( Fig. I B) . In addition, iNOS enzyme activity (quantified by measuring nitrite, an oxidation product of NOS (49), was increased by the same protocol of IFN-y and LPS treatment. and was blocked by addition of a fivefold molar excess of the competitive NO synthase antagonist L-NMMA (Fig. 2 A) . To test whether NO produced by stimulated macrophages was toxic to adjacent cardiac myocytes, both stimulated or unstimulated J774 macrophages plated on transwell inserts were placed over a lawn of adult rat cardiac myocytes. CPK release and trypan blue exclusion, measured as indices of myocyte death, were not significantly different between control myocytes and those cocultured with unstimulated macrophages (Fig. 2, B However, when the macrophages were stimulated with lipopolysaccharide and IFNy, myocyte death was 43% greater than controls (P < 0.05: Fig. 2 B) , and CPK release was 151% greater than controls (P < 0.05; Fig. 2 C) . Evidence indicating that the diffusible mediator produced by stimulated macrophages which killed adjacent myocytes was NO included the parallel increases in nitrite production, CPK release, and myocyte death (Fig. 2 A) , as well as the coincident inhibition of NO production and cytotoxicity by L-NMMA (Fig. 2 , A-C).
Because inducible NO synthase activity has been reported in cardiac myocytes (18, [41] [42] [43] , it was important to exclude a role for myocyte-derived NO as the cytotoxic agent in the coculture experiments. Myocytes which were plated in the absence of macrophages and stimulated with the identical concentrations of lipopolysaccharide and IFNy failed to produce more nitrite than unstimulated myocytes (4.0t0.2 vs. 4.8+0.3 pM, respectively, P = NS). This result indicates that the source of the increased NO production in the coculture experiments was the J774 macrophages. (41) .
In addition, IFN-y synergizes with TNF to induce NOS activity in vascular smooth muscle cells (15) . Accordingly, experiments were designed using identical adult myocyte preparations as in the coculture experiments, but exposed for 24 h to a triple cytokine combination consisting of IFNy, TNF-a, and IL-1/3 in the absence of J774 cells. After this treatment, Northern blotting using a macrophage iNOS cDNA probe revealed a single strong band (Fig. 3 A, right lane) migrating in a position similar to that seen in stimulated J774 cells (Fig. 1 A) . This band was completely absent in untreated control myocytes ( Fig.  3 A, left lane). Western blotting confirmed the induction of iNOS protein in purified adult rat ventricular myocytes stimulated with the same triple cytokine combination (Fig. 3 B, middle lane), and there were also corresponding increases in iNOS enzyme activity (Fig. 4 A) .
To establish whether cardiac myocyte iNOS may have an autotoxic role in cardiac myocytes exposed to cytokines, we evaluated cardiac myocyte death as described above for the coculture experiments. Cardiac myocytes stimulated with this triple cytokine combination released more nitrite and had 89% more CPK release (P < 0.05) and a greater percentage of dead cells at 24 h compared with unstimulated myocytes (59+2.3% vs. 38±1.5%, P < 0.05; Fig. 4 , B and C). As in the coculture experiments. L-NMMA inhibited the increased nitrite release and was completely protective against cytokine-induced cell death, with changes in nitrite release paralleling myocyte death in all instances (Fig. 4 A) . Representative trypan blue staining of myocytes is shown in (Fig. 5) . It can be seen that living myocytes had a characteristic rod-shaped/striated appearance at 24 h (45) . Although there is a background level of cell death at 24 h in all experiments, treatment with cytokines caused a marked increase in cell death (loss of membrane integrity resulting in the uptake of trypan blue), which was largely prevented by cotreatment with L-NMMA (Fig. 5) .
As inducible NO synthase activity is not subject to calciumdependent regulation (6, 14), we investigated whether inhibiting iNOS expression might prevent NO-mediated autotoxicity. Because transforming growth factor-,l (TGF-/3) has been shown to destabilize iNOS message and protein in macrophages (52, 53) and vascular smooth muscle cells (12, 13) , as well as inhibit cytokine-stimulated nitrite release from neonatal cardiac myo-
cytes (43), we investigated whether TGF-,l could similarly reduce iNOS activity in adult rat cardiac myocytes and so reduce cytokine-induced NO-mediated autotoxicity. Simultaneous treatment of purified adult rat ventricular myocytes plated for 24 h with both TGF-fl and TNF-a, IL-1,3, and IFNy resulted in markedly decreased expression of iNOS message (Fig. 3 A, middle lane) and protein ( Fig. 3 B, right lane) . TGF-,3 also had a remarkably obliterating effect on nitrite release from myocytes (both basal and cytokine-induced; Fig. 6 A) , which was associated with significantly less myocyte death in both the stimulated and unstimulated cardiac myocytes (Fig. 5, and Fig. 6 , B and C Figure 4 . Effects of cytokine treatment on cardiac myocyte nitric oxide synthesis and death. Experiments were performed as described in Fig. 2 , except that these experiments were performed in the absence of macrophages. IFN-y, tumor necrosis factor-a, and interleukin I-,f3 were used for stimulating myocyte iNOS expression where indicated. (A) Nitrite was measured as an index of nitric oxide synthesis and (B) trypan blue exclusion and (C) CPK release were used to quantify myocyte death. Adult rat ventricular myocytes express iNOS activity (increased nitrite production) after cytokine treatment, which coincides with the expression of iNOS message and protein (Fig. 3) and myocyte cell death (B and C). Addition of the competitive NO synthase inhibitor L-NMMA inhibits nitric oxide synthesis and myocyte death in parallel. Experiments for (A-C) were performed in 24-well tissue culture dishes and represent data from experiments performed on three separate weeks, analyzed by repeated measures ANOVA (*P < 0.05 vs. unstimulated controls).
dium, the data strongly suggests that myocyte killing was mediated by nitric oxide. Figure 6 . Effect of TGF-,6 on cardiac myocyte iNOS activity and cell death. Experiments were performed as described in Fig. 4 , except that TGF-,6 was used instead of L-NMMA. TGF-,f markedly attenuates nitrite accumulation (A) as well as iNOS mRNA induction and protein expression (Fig. 3) . TGF-,6-induced reduction of cardiac myocyte iNOS mRNA, protein, and activity correspond to a protection against myocyte death as measured by trypan blue exclusion (B) and CPK release (C). Experiments for A-C were performed in 24-well tissue culture dishes and represent data from experiments performed on three separate weeks, analyzed by repeated measures ANOVA (*P < 0.05 vs. unstimulated controls).
graft rejection. This concept is supported by data which demonstrates the presence of iron-nitrosyl electron paramagnetic resonance signals (characteristic of NO) (55) , increased nitric oxide synthase activity, and abundant iNOS-expressing macrophages in rejecting rat cardiac allografts (35) . The paracrine toxic effects of NO produced by activated macrophages adjacent to cardiac myocytes may be similar to those responsible for tumor target cell (20) (21) (22) , pancreatic islet (23-25), ovarian epithelial cell (28) , and hepatocyte (29) NO-mediated cytotoxicity. The second set of experiments was designed to determine whether NO produced by iNOS within cardiac myocytes might be autotoxic. Constilutive NO synthesis has been described in the endocardium (56, 57) and coronary vasculature (57-59), where it is likely to subserve important vasorelaxant and antithrombotic functions. Ventricular tissue from patients with dilated cardiomyopathies demonstrate the presence of both constitutive and inducible NOS activities (particularly the latter) (60) . Other studies have identified high output, Ca2+-independent NO synthase activity in the myocardium (41) as well as iNOS expression in neonatal cardiac myocytes (18). The current study confirms and extends this work by demonstrating that cytokines (TNF-a, IJL-113, and IFN-y) can induce iNOS mRNA, protein, and enzyme activity, and that NO so produced is autotoxic to the cardiac myocytes. This NO-mediated autotoxicity was prevented by either competitive NO synthase inhibition with the L-arginine analog L-NMMA, or by decreasing levels of iNOS transcripts and protein by coincident application of TGFwith the cytokines which induced iNOS. These findings of autotoxicity mediated by NO are not unique to ventricular myocytes. NO produced by macrophages (61) and endothelial cells (61) in response to cytokines has been reported to induce autotoxicity. Although the physiologic role of iNOS (and its highly toxic product, NO) within cardiac myocytes remains to be identified, it is possible that it subserves a similar immune function as it does in other cell types, protecting myocytes from viral or parasitic invasion. Support for this idea stems from a preliminary report of an increase in viral titers and mortality in a murine myocarditis model in which NOS inhibitors were given to mice infected with Coxsackie virus B3 (62) .
It is not surprising that nitric oxide is potentially toxic to cardiac myocytes. iNOS plays a critical microbicidal role, subserving important anti-bacterial (6, 8) , anti-rickettsial (63), antiparasitic (17, 19) , and anti-viral functions (62, 64, 65) , and may also be involved in the host response to tumor cells (20) (21) (22) . There are many potential mechanisms by which nitric oxide may mediate its toxic effects on cardiac myocytes. By analogy with other descriptions of NO-mediated cytotoxicity, these may include auto-ADP-ribosylation of glycolytic enzymes (66) , inhibition of ribonucleotide reductase (22) , activation of poly (ADPribose) synthetase (26) , inhibition of enzymes involved in the mitochondrial repiratory chain by the formation of iron-nitrosyl complexes (21, 55, 67, 68) , inhibition of the citric acid cycle enzyme aconitase (25), formation of toxic species such as peroxynitrite (9), or triggering of cardiac myocyte apoptosis (61) . In rejecting cardiac allografts, the increased electron paramagnetic resonance "signature" of NO bound to heme and nonheme containing proteins (55) in association with myocyte necrosis suggests that this may be one important mechanism of NO-mediated toxicity within the heart. The single or multiple mechanisms whereby NO mediates its toxic effects on cardiac myocytes is currently the subject of further investigation in our laboratory.
Because iNOS produces a highly toxic product (nitric oxide) that is not subject to the calcium-dependent regulation (to which cNOS is subject) (9) (10) (11) 14) , powerful mechanisms have evolved to modulate iNOS expression. TGF-/3 has been shown to downregulate iNOS expression in macrophages by three distinct mechanisms, including (a) decreased stability of iNOS mRNA; (b) decreased translation of iNOS mRNA; and (c) increased degradation of iNOS protein (53). Similarly, TGF-,f has been shown to inhibit NO synthase activity in vascular smooth muscle cells (12, 13) . In neonatal cardiac myocytes, TGF-,B has been shown to antagonize the inhibitory effects of NO on beating rate, as well as to inhibit iNOS activity and protein synthesis (43) . In the studies presented here, we have shown that TGF-,B suppresses iNOS message, protein, and activity in adult rat cardiac myocytes, and that this inhibitory effect of TGF-,/ on cytokine-induced iNOS expression blocks NO-mediated autotoxicity.
In addition to a depression of ventricular contractility that may result from the death of myocytes within the heart, there is abundant evidence to suggest that NO inhibits the contractility and beating rate of cardiac myocytes (30) (31) (32) (33) (34) (35, (69) (70) (71) (72) (73) . Supernatants from activated mononuclear cells (74) and the proinflammatory cytokines TNFa and IL-1p6 (75, 76) have negative inotropic effects on cardiac myocytes in culture as well as in isolated beating hearts (72). NO produced by either constitutive or inducible NOS within rat heart muscle cells inhibits the positive inotropic effects of beta adrenergic agonists (31) , and exogenous administration of NO or iNOS induction by endotoxin administration impairs the contractility of guinea pig cardiac myocytes (32) . Recent work has delineated a role for cytokine-induced NO synthesis in the negative inotropic effects observed following cytokine administration (30-32, 34), probably mediated by cGMP (77) (78) (79) . These observations, as well as data from the current study confirming endogenous cardiac production of nitric oxide, suggest that nitric oxide may also depress myocardial contractility independent of myocyte killing.
The finding that cytokines themselves induce myocyte autotoxicity without the requirement for adjacent NO-producing cells may be especially relevant for those conditions associated with elevated circulating levels of cytokines without a notable inflammatory infiltrate (4, 5, (80) (81) (82) (83) . This is potentially very relevant to the pathophysiology of various cardiac disease states, including the inexorable progression of end-stage heart failure, which has been associated with elevated circulating levels of TNF (4, 5) , as well as cardiac allograft rejection, in which a multitude of cytokines are expressed in the local milieu (3). In addition, nearly one fifth of all cases of dilated cardiomyopathy are associated with a nonspecific myocarditis characterized by an inflammatory infiltrate (37) , also suggesting the local presence of a cytokine-rich milieu. In addition to these observations, case reports of cytokine-induced cardiac toxicity leading to irreversible cardiomyopathy abound (37, (80) (81) (82) (83) , with infusions of IFN-a, TNF-a, or IL-2 implicated as offending agents. One recent trial demonstrated a survival benefit in patients with heart failure treated with a therapy (84) which has potent anti-cytokine properties as a major side effect (85) . The identification of elevated cardiac iNOS activity in patients with dilated cardiomyopathy (60) and confirmation of recombinant-cytokine induced NO production in man (86) further support the potential clinical relevance of these observations. Taken together, these experiments demonstrate that NO is potentially cardiotoxic, whether it is produced by adjacent inflammatory cells or by cardiac myocytes themselves exposed to a cytokine-rich mileu. These findings may help explain the inexorable progression and demise of many patients with cardiomyopathies of diverse etiologies, and suggest potential therapeutic strategies to limit ongoing myocardial damage in transient high cytokine states, including sepsis, anti-tumor therapy with recombinant cytokines, cardiac allograft rejection, infarction, and myocarditis. These studies raise the possibility that NO-mediated cytotoxicity represents a final common pathway for the myocardial damage caused by proinflammatory cytokines or inflammatory cellular infiltrates, and that blocking iNOS expression or activity may be of potential therapeutic benefit.
